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Mass spectrometry-based proteomics now enables
the absolute quantification of thousands of pro-
teins in individual cell types. We used this technol-
ogy to analyze the dynamic proteome changes
occurring during human erythropoiesis. We quanti-
fied the absolute expression of 6,130 proteins dur-
ing erythroid differentiation from late burst-forming
units-erythroid (BFU-Es) to orthochromatic erythro-
blasts. A modest correlation between mRNA and
protein expression was observed. We identified
several proteins with unexpected expression pat-
terns in erythroid cells, highlighting a breakpoint
in the erythroid differentiation process at the baso-
philic stage. We also quantified the distribution of
proteins between reticulocytes and pyrenocytes af-
ter enucleation. These analyses identified proteins
that are actively sorted either with the reticulocyte
or the pyrenocyte. Our study provides the absolute
quantification of protein expression during a com-
plex cellular differentiation process in humans,
and it establishes a framework for future studies
of disordered erythropoiesis.
INTRODUCTION
Healthy humans produce around two million red cells each sec-
ond of their lives. This tightly regulated process takes place in the
bone marrow, and it begins with a restriction in the potency of
multipotent hematopoietic stem cells to lineage-specific progen-
itor cells, such as progenitors strictly committed to the erythroid1470 Cell Reports 16, 1470–1484, August 2, 2016 ª 2016 The Author
This is an open access article under the CC BY-NC-ND license (http://lineage. The second step is an amplification phase in which
erythroid progenitors proliferate extensively under the control
of several growth factors.
Although these cells aremorphologically indistinguishable and
their maturation process is continuous, two kinds of erythroid
progenitors are successively distinguished. The first erythroid-
committed progenitors are burst-forming units-erythroid (BFU-
Es), which require stem cell factor (SCF), but not erythropoietin
(EPO), for proliferation. In contrast, EPO is absolutely required
for the survival and proliferation of the late erythroid progenitors
called colony-forming units-erythroid (CFU-Es). The last phase
of erythropoiesis is terminal differentiation. In this step, several
morphologically recognizable precursors are successively pro-
duced: proerythroblast (ProE) cells and basophilic I and II
(Baso1 and Baso2), polychromatophilic (Poly), and orthochro-
matic (Ortho) erythroblasts. During this process, the size of the
cells gradually decreases, and they synthesize large amounts
of hemoglobin (Hb) and reorganize their membrane with accom-
panying nuclear condensation. At the end of terminal erythroid
differentiation, Ortho cells expel their nucleus, which is sur-
rounded by plasma membrane with a small amount of cyto-
plasm, to generate a pyrenocyte, which is rapidly engulfed by
macrophages of the erythroblastic niches, and a reticulocyte,
which completes its maturation in the bloodstream. During this
enucleation process, several proteins appear to be actively
sorted between pyrenocytes and reticulocytes, although the
extent of this active sorting process remains unclear.
Erythropoiesis is studied extensively both as a differentiation
paradigm and because red blood cells are involved in many
serious human diseases. Although several aspects are well un-
derstood at the molecular level, a global and integrated analysis
of this differentiation process is required. Several transcriptomic
analyses of erythropoiesis have been published, leading to the
determination of the expression pattern of 8,500–12,000 genes(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Experimental Designat different differentiation stages (An et al., 2014; Kingsley et al.,
2013; Li et al., 2014; Merryweather-Clarke et al., 2011; Shi et al.,
2014). In contrast, a deep proteomic analysis of this differentia-
tion process is still lacking. Because the relationship between
mRNA and protein expression is far from straightforward (Vogel
and Marcotte, 2012), a comprehensive characterization of the
proteome of erythroid cells during their differentiation is now
essential to better understand both normal erythropoiesis and
the pathologies affecting this process.
Current proteomic methods allow the identification of several
thousand proteins from microgram quantities of proteins.
Robust comparative quantification methods were first devel-
oped by using differential labeling with stable isotopes. Until
recently, the most widely used labeling method was the
stable isotope labeling by amino acids in cell culture (SILAC)
method (Mann, 2006). The major drawback of this powerful
method is that primary cells usually do not proliferate enough
in cell culture to allow the complete replacement of amino
acids. Several methods to chemically label peptides, such as
isobaric tags for relative and absolute quantitation (ITRAQ),
have been developed to overcome this limitation. Today, effi-Cell Recient label-free quantification (LFQ)
methods combine high-accuracy mass
measurement of peptides using recently
developed mass spectrometers with
their reproducible retention time in the
chromatographic step to quantitatively
compare peptide populations in succes-
sive liquid chromatography-tandem
mass spectrometry (LC-MS/MS) ana-
lyses. Key improvements to these
methods were the development of highly
efficient algorithms to align chromato-
grams from successive analyses (Cox
et al., 2014) and the creation of absolute
quantification procedures from label-
free data (Wisniewski et al., 2014).
In the present study, we analyzed the
proteome of erythroid cells at different
differentiation stages by an LFQ method.
We used the recently described stan-
dardization method based on the MS
signal of histone peptides to quantify the
absolute copy number of more than
6,100 proteins, providing the most
comprehensive proteomic database of
erythropoiesis available to date. More-
over, we used an ITRAQ labeling method
to quantify the segregation of 1,318 pro-
teins between pyrenocytes and reticulo-
cytes following enucleation. Cytoplasmic
volumes and surface areas of pyreno-
cytes and reticulocytes were calculated
from imaging flow cytometry, and theywere used to estimate whether these proteins are passively or
actively sorted into each cell type. The overall flowchart of the
study design is presented in Figure 1.
RESULTS AND DISCUSSION
Erythroid Cell Populations
Our goal to decipher the modifications of the erythroid cell pro-
teome during terminal differentiation required access to suffi-
cient amounts of homogenous cell populations at different differ-
entiation stages. Two potential strategies are available to obtain
such material: either purification of cells at the different differen-
tiation stages by flow sorting using specific cell surface markers
or maintenance of a high level of synchrony in the cultures during
the differentiation process. The latter strategy was chosen for the
proteomic studies due to the limited ability of the sorting
approach to generate sufficient amounts of stage-specific
erythroid cell populations for analysis.
Starting from purified CD34+ cell populations from cord blood,
a two-step culture method was modified to obtain highly homog-
enous erythroid cell populations at different differentiation stagesports 16, 1470–1484, August 2, 2016 1471
(see Experimental Procedures and Figure 2A). First, CD34+ cells
were cultured for 7 days in the presence of IL3, IL6, and SCF to
allow the proliferation of early progenitors. Erythroid cells were
then purified using the CD36marker to generate a cell population
essentially composed of progenitors, because, without EPO, the
erythroid cells failed to survive to the CFU-E stage. Starting from
this step, cells were cultured in the presence of EPO and charac-
terized each day both phenotypically by flow cytometry and
morphologically by May-Gr€unwald-Giemsa (MGG) staining (Fig-
ures 2B, 2C, and S1). The cell populations were sampled daily
for proteome analysis, although daily sampling of cells was not
feasible in all experiments at the progenitor stage due to a scarcity
of material (Figure 2D).
Overall, terminal differentiation from the CD36+ cell purifica-
tion to the Ortho stage lasted 10 ± 1 days, and the amplification
level was around 300-fold (Figure 2B). We distinguished two pro-
genitor populations (Prog1 and Prog2) based on the expression
levels of CD71 and CD34. The Prog1, but not Prog2, population
expressed CD34 (Figure S1). Clonogenic cultures of CD36-
sorted cells showed that the Prog1 population was mainly
composed of late BFU-Es (Figure S1), in agreement with their
overall amplification potential and the simultaneous expression
of both CD34 and CD36 markers. Overall, we identified cell pop-
ulations at seven distinct differentiation stages for data analysis
(Figure 2C). Transition from one stage to the next took around
24 hr, although the differentiation process seemed to slow
down slightly at later stages, leading to the grouping of 2 consec-
utive culture days to the same differentiation stage (Figure 2D).
Four independent cultures established from four different cord
blood samples were used for the proteomic analysis. Due to
some biological variability, the duration of terminal differentiation
ranged from 9 to 11 days. Each daily sampled cell population
was analyzed separately by MS, and data from the four experi-
ments were grouped according to Figure 2D for analysis. After
this grouping, each cell population contained more than 50%
of cells at the main differentiation stage, and more than 90% of
the cells corresponded to the main differentiation stage and
the stages just before and after this stage. As such, the set of
samples used for the analysis accurately represents the entire
erythroid differentiation process (Figure 2E).
Proteomic Analysis of Erythroid Cell Populations
To improve proteome coverage using the match between run
(MBR) algorithm of MaxQuant software (Deshmukh et al.,
2015), extracts from two cell lines with erythroid characteristics,
UT7 and K562, were analyzed simultaneously with primary
erythroid cells (validation of the MBR algorithm is presented in
the Supplemental Experimental Procedures and Figure S2).
This led to the identification of 7,361 proteins expressed in pri-
mary erythroid cells with a false discovery rate below 1% (Table
S2). The mean sequence coverage of these proteins was 26.4%
± 2.4%. We applied the recently described proteomic ruler to
determine the absolute expression of these proteins, using the
total MS signal of all core and linker histones and a histone con-
tent of 6.5 pg/human cell. This method requires that at least
12,000 peptides be identified in each experiment and that MS
signals of at least two different peptides be measured for each
protein to be quantified (Wisniewski et al., 2014). Between1472 Cell Reports 16, 1470–1484, August 2, 201615,566 and 40,626 peptides were identified for each sample,
enabling us to apply this method to all cell samples in each
experiment and leading to the absolute quantification of 6,160
proteins. All subsequent calculations and their discussion are
restricted to these quantified proteins.
Around 5,000 proteins were quantified at each differentiation
stage, although this value was slightly lower at the final stages
of differentiation (Figure 3A). This could be either due to a
decreased number of proteins expressed in the late stages of dif-
ferentiation and/or the high amounts of Hb that accumulate at
these stages, which could reduce the identification efficiency
of minor proteins via an ionization suppression effect. Most pro-
teinswere quantified in all of the seven differentiation stages, and
only 550 proteins were observed in a single cell population (Fig-
ure 3B). Pearson correlation analysis revealed high homologies
between the different populations (Figure 3C), indicating both
the reproducibility of these analyses and the relative stability of
the expression of many proteins during differentiation, despite
strong modifications of the cells. Thus, these results confirm
the observation realized at the transcriptomic level that most
genes active during terminal differentiation are already ex-
pressed at the ProE stage (Kingsley et al., 2013). Both hierarchi-
cal clustering analysis (Figure 3D) and Pearson correlation anal-
ysis (Figure 3C) of these quantitative data confirmed the
continuous evolution of the erythroblast proteomes according
to the differentiation stages of erythroid cells. Expression of clas-
sical erythroid differentiation markers (CD36, TFRC, band 3,
GPA, CD44, CD45, ITGa4, and c-KIT) followed the expected pat-
terns (Figure S3A). The expression pattern of several selected
proteins also was verified by western blot analysis (Figure S3B).
All of these results show that the proteomic analyses accurately
reflected the evolution of erythroid cells during terminal
differentiation.
To verify the accuracy of the quantitative analysis, the total
amount of protein content per cell was calculated from the pro-
teomic analysis and compared with the amount directly deter-
mined from protein quantification and cell counting. Although a
slight systematic difference between the two determinations
was observed that could be due to the use of BSA as a protein
standard for protein quantification, the evolution of cell protein
contents along erythroid differentiation was very similar when
calculated by either of the twomethods (Figure 3E). We checked
the relative expression of proteins involved in stable protein
complexes containing one copy of each protein subunit, such
as ribosome subunits or proteasome. For each complex, very
similar numbers of each protein of the complex were quantified
(Figure 3F). Lastly, we compared our quantification results with
previously published data; however, except for a few proteins
regulating erythropoiesis, such as hormone and growth factor
receptors, most available data deal exclusively with mature
erythrocyte proteins. To increase the number of values for the
comparison, we made the assumption that most proteins of
the circulating red cells would have been synthesized already
by the Ortho stage. For this comparison, protein expression
extended to nearly five logs, from 3,000 copies per cell for the
glucocorticoid receptor to up to 270 3 106 copies for Hb. This
analysis confirms the accuracy of the quantitative proteomic
data (Figure 3G). Altogether, these controls strongly suggest
Figure 2. Erythroid Cell Cultures
(A) Culture protocol is shown.
(B) Amplification rate of a typical culture is shown.
(C) Characterization of the differentiation stages in a typical culture. Upper panel: MGG staining of cytocentrifuged cells is shown; middle panel: flow cytometry
analysis of integrin alpha 4 (CD49d) and band 3 expression is shown; lower panel: phenotypic characteristic features of the cell populations are shown.
(D) Cell sample grouping for data analysis. Cell samples from the four experiments were regrouped in seven categories according to the phenotypes described in
(C) and MGG staining. Up to day 3, the unanalyzed samples did not contain enough material for analysis and two samples of experiments E1 (D6 and D9) that
presented an equal mixture of two differentiation stages were not analyzed.
(E) Cell composition of each cell category. For each category resulting from the grouping presented in (D), the mean composition ± SD was calculated according
to the erythroblast morphology determined by MGG staining.
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Figure 3. Absolute Proteome Quantification
during Terminal Differentiation of Erythroid
Cells
(A) Total number of quantified proteins in each
differentiation stage is shown.
(B) Number of quantified proteins according to the
number of differentiation stages in which they have
been quantified is shown.
(C) Pearson correlation analysis of quantified pro-
tein expression between the differentiation stages
is shown.
(D) Hierarchical clustering analysis of quantified pro-
teins at the different differentiation stages is shown.
(E) Determination of the total protein content per
cell during differentiation. BCA curve: the amount
of protein per cell was calculated by dividing the
total amount of protein determined by a bicincho-
ninic acid assay using BSA as a standard by the
number of cells. MS curve: the amount of protein
per cell was calculated as the sum of the amount of
each protein quantified by MS after standardiza-
tion to the histone MS signal.
(F) Protein copy number in stable multimeric
complexes at the ProE stage. Selected multimeric
complexes contain between 14 (20S proteasome)
and 44 (ribosome large subunit) different proteins
with a single copy for each of them in the complex.
(G) Comparison of protein expression values deter-
mined by LFQ with published expression values.
Except for c-KIT and the glucocorticoid receptor,
which were measured in erythroid progenitors (Dai
et al., 1994;Mayeuxet al., 1983), all published values
corresponded to protein expression in erythrocytes
(Burton andBruce, 2011). Theywere comparedwith
values determined in Ortho cells.
(H) Protein expression range. The overall curve was
drawn using the highest expression value of each
protein irrespective of the differentiation stage.that the data constitute an accurate determination of the abso-
lute concentrations ofmost proteins expressed by erythroid cells
along their terminal differentiation, and they confirm the accu-
racy of quantification methods based on histone signal stan-
dardization. These findings also show that the nuclear conden-
sation occurring during erythroid differentiation does not
significantly affect the overall histone content of the cells.
The expression range of identified proteins encompassed
more than seven logs, ranging from tens of copies per cell for
proteins such as MYB to several hundreds of millions for HBA
or HBB. As expected, because the size of erythroblasts de-
creases during differentiation, the median number of protein1474 Cell Reports 16, 1470–1484, August 2, 2016copies per cell decreased from 30,000
copies/cell at the progenitor stage to
6,000 copies at the Ortho stage
(Figure 3H).
Evolution of Gene and Protein
Expression during Erythroid
Differentiation
The total protein content of erythroblasts
decreased during differentiation, with the
cells simultaneously accumulating Hb. At the Ortho stage, Hb
chains and AHSP, the molecular chaperone of Hba chains,
constituted 50% of the total cellular protein content (Figure 4A).
At the progenitor or ProE stage, the 25 most abundant proteins
constituted around 25% of the total protein mass of the cell,
whereas at the Ortho stage they constituted more than 60%.
This is due to Hb accumulation because, if its mass was sub-
tracted, the contribution of the 10, 25, or 50 most abundant pro-
teins remained constant throughout the cell differentiation pro-
cess. Consequently, the real decrease in protein amounts per
cell along erythroid differentiation reached 75% at the Ortho
stage compared with the ProE stage (Figure 4B). This value
Figure 4. Evolution of the Proteome during
Erythroid Terminal Differentiation
(A) Contribution of the 10, 25, and 50 most abun-
dant proteins to the entire protein content of the
cell. The calculations were done with all proteins
(Hb+) or after removal of the contributions of Hb
chains and AHSP (Hb). The Hb curve shows the
contribution of hemoglobin chains and AHSP to
the overall cell protein content.
(B) Evolution of the cellular protein content after
subtraction of hemoglobin and AHSP contribu-
tions is shown.
(C–E) Quantitative expression of erythroid-specific
transcription factors (C), splicing complexes pro-
teins (D), and translation machinery proteins (E).
Medians of protein expression are indicated for
multiproteinic translation complexes (asterisks).was used to compare the evolution of the erythroid cell proteome
during the differentiation process.
Proteins differentially expressed during erythroid differentiation
were extracted by a multi-sample ANOVA test and submitted to
k-means clustering analysis. As expected, most differentially ex-
pressed proteins decreased during erythroid differentiation (see
Figure S4 and Table S3, clusters 1 and 2). Functional annotation
analysis of these two clusters showed a significant enrichment
of proteins related to general cellular processes, such as RNACell Reprocessing, translation, metabolism, intra-
cellular transport, proteasome degrada-
tion, and DNA replication and repair.
Cluster 3 regrouped 40 proteins that
significantly increased during differentia-
tion. In addition to proteins involved in
erythroid differentiation, such as Hb,
band 3, SLC2A1 (GLUT1), SPTB, AHSP,
or HEMGN (EDAG), this cluster also con-
tained proteins such as optineurin
(OPTN), an autophagy inducer; histone
H1F0, a variant histone linker; and PHOS-
PHO1, a phosphatase involved in bone
mineralization. A fourth cluster showed
proteins such as LEPR or IRF6, which
peaked at the ProE/Baso1 stage and
then decreased. The roles of these pro-
teins in erythroid differentiation remain
unknown.
Gene ontology (GO) analysis revealed a
classical repartition of proteins among the
different cellular compartments, including
the presence of many membrane and
secreted proteins (Figure S4). In total,
428 proteins with sequence-specific
DNA-binding transcription factor activity
or transcription cofactor activity accord-
ing to GO were identified among the
quantified proteins, including all specific
transcription factors regulating erythro-
poiesis (Figure 4C).The two STAT5 isoforms were expressed to different levels,
with STAT5A being significantly more highly expressed than
STAT5B at all differentiation stages. It is currently unknown
whether each STAT5 isoform has different activities in erythroid
cells, as has been reported recently in chronic myeloid leukemia
cells (Casetti et al., 2013). Except for NFE2, expression of
erythroid-specific transcription factors was already maximal at
the progenitor or ProE stage, ranging from 10,000 to 50,000
copies per cell at these stages. GATA1, KLF1, and Tal1 areports 16, 1470–1484, August 2, 2016 1475
considered the master regulators of erythroid terminal differenti-
ation. Their expression patterns were very similar, with a
decrease at the end of differentiation that roughly followed the
4-fold decrease in the whole protein content of erythroblasts
during their differentiation. GATA1 and KLF1 were both ex-
pressed at around 50,000 copies per cell at the ProE stage.
These values should be compared with those of their DNA-bind-
ing sites determined by chromatin immunoprecipitation seq-
uencing (ChIP-seq) or ChIP followed by 50-to-30 exonuclease
treatment and then massively parallel DNA sequencing (ChIP-
exo) studies, although the published determinations present var-
iations, leading to some uncertainty as to the true number of DNA
targets. Around 15,000 and between 5,700 and 10,000 DNA-
binding sites have been identified for KLF1 and GATA1, respec-
tively (Fujiwara et al., 2009; Han et al., 2015; Kassouf et al., 2010;
Pilon et al., 2011). This suggests that enough molecules of these
transcription factors should be present at each differentiation
stage to regulate the entire set of their target genes. TAL1 follows
the same expression kinetics as that of GATA1 and KLF1, but its
expression level appears to be around 5-fold lower at all stages
of differentiation. At several differentiation stages, TAL1 expres-
sion was close or even below the 15,000 DNA-binding sites iden-
tified in erythroid cells by ChIP-exo (Han et al., 2015), although
other studies identified less than 3,000 DNA-binding sites for
TAL1, suggesting that these sites have different affinities (Kas-
souf et al., 2010). The expression levels of ETO2, LMO2,
STAT5A, and STAT5Bwere strongly decreased at the late stages
of differentiation compared with the overall decrease in cell pro-
tein content. In contrast, NFE2 expression increased, and NFE2
appeared to be more highly expressed than other erythroid tran-
scription factors, such as GATA1 and KLF1, at the end of the
differentiation process.
Several of these proteins associate with each other to consti-
tute transcription complexes of different compositions and func-
tions. Our data should allow the determination of which of these
proteins is the limiting factor for the constitution of these com-
plexes at the different differentiation stages. Indeed, FOG, which
associates with GATA1 to constitute either repressive or acti-
vating transcription complexes, appeared to be 10-fold less ex-
pressed than GATA1. Cell fractionation analyses confirmed that
all GATA1 proteins and most FOG1 proteins were localized to
the nucleus of erythroblasts, showing that their relative nuclear
concentrations could be deduced from their expression in
whole cells (data not shown). Similarly, TAL1 should be the
limiting element for the constitution of the LDB1 complexes.
Thus, our data should contribute to the development of
improved models of transcriptomic regulation during erythropoi-
esis by providing the quantitative expression pattern of most
transcriptional regulators.
A high level of alternative splicing occurs during the late stages
of differentiation, which has been suggested to significantly
contribute to the proteome diversity during erythropoiesis (Pi-
mentel et al., 2014). Our results show that the main splicing com-
plexes followed the generally decreased protein expression be-
tween the ProE and Ortho stages (Figure 4D).
Most proteins involved in the translation machinery undergo
the same 4-fold decrease (Figure 4E), despite the huge amount
of Hb synthesis. Interestingly, erythroid cells expressed 4E-BP1476 Cell Reports 16, 1470–1484, August 2, 2016proteins at a level similar to that of eIF4E at the early differ-
entiation stages, whereas expression of the 4E-BP proteins
decreased more strongly than the expression of eIF4E at the
end of differentiation. This suggests that a strong regulation of
protein translation through mTORC1 could occur at the early
stages of differentiation, whereas, in late stages, only a limited
fraction of protein translation should be subjected to regulation
through this pathway. This regulation could especially target
globin synthesis, as previously reported (Chung et al., 2015).
On the other hand, EIF2AK1 (HRI) expression was below the
detection threshold at the progenitor stages and increased
strongly during differentiation, implying that the overall protein
synthesis is primarily regulated by heme availability in terminally
differentiating cells.
Relation between the Transcriptome and Proteome
during Erythropoiesis
We used the recently published transcriptomic analyses of
differentiating erythroid cells from human cord blood (An et al.,
2014; Li et al., 2014) to compare mRNA and protein expressions.
In these studies, BFU-E cells were purified according to the lack
of CD36 expression and corresponded to young BFU-Es (Li
et al., 2014). Thus, the Prog1 population that we purified was
more mature than the BFU-E cells analyzed by Li et al. (2014),
whereas the Prog2 population could be equated to CFU-E cells.
Li et al. (2014) performed the transcriptomic studies with
polyadenylated RNA. Because histone mRNA is not polyadeny-
lated, histones were removed from the comparison. Transcrip-
tomic and proteomic data revealed, as usual, a limited correla-
tion with Spearman’s rank correlation coefficients varying
from 0.410 to 0.676 (Figure 5A). Few of the 20 most expressed
proteins correlated with the 20 most expressed mRNA, except
for globins at the last stages of differentiation (Table S1). Fig-
ure 5B shows two examples of highly expressed proteins
whose expression modifications during differentiation followed
(GAPDH) or not (TUBB4B) the pattern of mRNA expression, con-
firming that protein expression cannot be deduced directly from
mRNA expression (Vogel and Marcotte, 2012).
We selected the genes with the most divergent patterns of
mRNA and protein expression using Spearman’s correlation
analysis. This led to the identification of 302 genes presenting
an opposite evolution of mRNA and protein expression during
differentiation. All of these genes except one showed the same
increased mRNA expression associated with decreased protein
expression (Table S4). Analysis of this set of genes suggested
neither their regulation by common transcription factors accord-
ing to TRANSFAC nor a biased representation of housekeeping
genes as previously defined (Kim et al., 2014a). Interestingly, this
analysis revealed the highly significant enrichment of genes with
intron-retaining mRNA that has been identified recently in eryth-
ropoiesis (Edwards et al., 2016; Pimentel et al., 2016). Moreover,
searching for Kyoto Encyclopedia of Genes and Genomes
(KEGG) and GO term enrichment showed an overrepresentation
of genes involved in RNA processing (Table S4), which also has
been suggested to be regulated by intron retention during eryth-
ropoiesis (Edwards et al., 2016; Pimentel et al., 2016). Alto-
gether, our data strongly support the recent hypothesis that
intron retention participates in the regulation of gene expression
Figure 5. Protein versus mRNA Expression Analysis along Erythroid Differentiation
Transcriptomic data from An et al. (2014) and Li et al. (2014) were compared with quantified proteins.
(A) Spearman rank correlation analysis is shown.
(B) mRNA and protein expression of GAPDH and TUBB4B in erythroid cells during differentiation is shown.
(C) Contribution of the ten most expressed mRNA to the whole mRNA expression is shown.
(D) Spearman rank correlation analysis after mRNA/protein standardization. A correction factor was calculated for each gene expression value by dividing the
protein copy number at the ProE stage by its mRNA quantification value. These correction factors were used to calculate a modified mRNA value that integrated
translation efficiency and protein stability. A new Spearman rank correlation analysis was performed with these modified values.
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during erythropoiesis. Of note, we identified SF3B1, which plays
a major role in sideroblastic anemia.
Overall, the cell composition appeared more stable at the pro-
tein than at themRNA level, andmany strong variations detected
at the mRNA level were buffered at the protein level. For
example, XPO7 expression increased more than 100-fold be-
tween the ProE and Ortho stages at the mRNA level but only
2-fold at the protein level. Some of this discrepancy could be
due to an overestimation of the mRNA variations that are calcu-
lated from relative expression values and, thus, do not integrate
the cell size decrease during the differentiation process. Modifi-
cations in the translation machinery and its controls also should
participate in this discrepancy. At the ProE stage, the ten most
abundant mRNA constituted only 9.6% of the whole mRNA con-
tent, whereas they constituted 67% of the mRNA content at the
Ortho stage (Figure 5C). It is unclear how late erythroblasts
manage the simultaneous translation of a few highly expressed
mRNA encoding erythrocyte-specific proteins and of many
others encoding housekeeping and regulatory proteins. Spear-
man’s correlation analysis showed that the correlation between
protein and mRNA worsened for the last steps of differentiation
(Figure 5B). To confirm this result, we calculated the protein/
mRNA ratio for each quantified protein at the ProE stage, and
we applied these correction factors to mRNA expression levels
for each differentiation stage. Spearman’s correlation analysis
using these modified values showed that the relationship be-
tween mRNA and proteins remained roughly constant up to
the Baso2 stage, with correlation coefficients above 0.9, and
then strongly decreased (Figure 5D), suggesting that different
mechanisms regulatingmRNA translation and/or protein stability
are in play in the late stages of differentiation.
Quantitative Proteomics Reveals New Aspects of
Erythropoiesis
Our analysis revealed the expression of several unexpected
proteins. Although our study design did not favor the identifica-
tion of secreted proteins, we identified several soluble proteins
produced by erythroid cells, such as GDF15, but also several
secreted proteins not previously reported. We detected the
presence of IL18 and hemopexin (HPX) in erythroblasts. IL18
also was detected at the mRNA level throughout the differentia-
tion process (An et al., 2014). Its role in this process remains un-
clear. In contrast, HPX was not detected at the mRNA level, sug-
gesting that, similar to transferrin, exogenous HPX proteins
specifically associate with erythroid cells. HPX is a plasma pro-
tein with a high affinity for free heme that targets it to the liver
for degradation while neutralizing its deleterious oxidizing ca-
pacities. We confirmed the presence of HPX in erythroid cells
by western blot analysis (Figure S3B). CD91 (LRP1), the hepatic
and macrophage HPX receptor (Hvidberg et al., 2005), also was
quantified in the proteomic analysis, and we confirmed its
expression pattern bywestern blot analysis (Figure S3B). In addi-
tion to HPX, CD91 is involved in the uptake of several plasma
proteins, including alpha macroglobulin, which also accumu-
lated in erythroid cells at the same differentiation stages (Table
S2). Interestingly, CD91 expression and HPX accumulation pre-
sented a very transient pattern, and these proteins were essen-
tially expressed at the basophilic stages when globin expression1478 Cell Reports 16, 1470–1484, August 2, 2016started to rise (Figure 4A). These results suggest that the eryth-
roblasts are able to internalize heme at the beginning of the he-
moglobinization process to contribute to Hb production.
Overall, our results show that the basophilic stages appear to
constitute a major milestone in the differentiation process, as re-
vealed by the unsupervised clustering analysis that introduced
the first dichotomy between the Baso1 and Baso2 stages (Fig-
ure 3D). Interestingly, the basophilic stages appear to constitute
a major difference between murine and human erythropoiesis,
because an extra cell division occurs in humans at this stage.
At the Baso2 stage, the expression of globins, band 3, and
GPA started to rise (Figures 4A and S3), whereas c-KIT expres-
sion dramatically decreased (Figure S3). At this stage, many pro-
teins from the splicing machinery also started to decrease (Fig-
ure 4D). EPOR expression decreased strongly at the murine
basophilic stage (Zhang et al., 2003). Although we could not
quantify EPOR expression in these studies, likely because the
presence of EPO induces the downregulation of its receptor,
our data show that expression levels of STAT5A (Figure 4C)
and TFR2 (Table S1), two proteins involved in EPOR signaling,
also strongly decreased at the basophilic stages. A transient
caspase activation process required for the achievement of ter-
minal differentiation occurs at the basophilic stage (Zermati
et al., 2001). It is tempting to speculate that the decreased intra-
cellular signaling due to c-KIT and possibly to EPOR downregu-
lation is responsible for these key modifications at this step.
Because of its function as an oxygen and carbon dioxide
transporter, the erythrocyte is highly exposed to oxidative stress,
with 0.5%–3% of its Hb content auto-oxidizing each day to form
methemoglobin and a superoxide radical. Survival of the erythro-
cyte for up to 120 days in the bloodstream is thus highly depen-
dent on the establishment of a robust machinery to both buffer
the oxidizing species and repair damaged proteins and lipids.
The erythrocyte redox system cannot be separated from glucose
metabolism, which constitutes the only metabolic pathway able
to both supply ATP and reduce pyridine nucleotides in these
cells. Accordingly, mutations in several key enzymes of these
pathways, such as PK or G6PD, are responsible for hereditary
hemolytic anemia in humans.
Our results give new insights into the establishment of the en-
zymes of these pathways. Transcriptomic analyses showed that
the expression of several genes of these pathways was strongly
increased at the Ortho stage. Nevertheless, except for BPGM
and GLUT1, a corresponding increase in protein expression
was never observed (Figure 6). BPGM plays a key role in eryth-
rocytes by regulating Hb affinity for O2 through 2-3BPG synthe-
sis. It would be interesting to determine the pattern of BPGM
expression in adult erythroblasts, because cord blood erythro-
blasts express 37.7% ± 3.6% of fetal Hb, which presents a low
affinity for 2-3BPG in contrast to adult Hb. Erythroid cells use
different glucose transporters. In mice, fetal erythrocytes ex-
press GLUT1 and there is a postnatal switch from GLUT1 to
GLUT4, whereas glucose enters human erythrocytes using
GLUT1 transporter, which also allows dehydroascorbic acid
(DHA) uptake after its association with stomatin (Montel-Hagen
et al., 2008). Because stomatin is still highly expressed during
the early stages of erythroid differentiation, this suggests
that young progenitor cells already possess high DHA uptake
Figure 6. Setting up of the Erythrocyte Glucose and Redox Metabolic Pathways during Erythropoiesis
Except for SLC2A3, which is probably no longer detectable in mature erythrocytes, the figure is restricted to proteins expressed in mature erythrocytes. Themain
part of the figure shows their expression levels at the Ortho stage. Genetic defects of enzymes labeled in red are responsible for red cell pathologies in humans.
The panels in the left part of the figure represent the evolution of mRNA and protein expression during the seven differentiation stages of terminal erythropoiesis
defined in Figure 2. Transcriptomic expression values are from An et al. (2014) and Li et al. (2014).potential and thereby buffer the oxidizing environment resulting
from the high iron content at this stage. We found that GLUT3
(SLC2A3) was expressed at the early stages of human erythroid
differentiation at levels similar to that of GLUT1 (SLC2A1) andthat its expression decreased rapidly while GLUT1 expression
increased dramatically.
Deficiency of the R isoform of PK is the most frequent
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hereditary hemolytic anemia. The M isoform of PK is expressed
at higher levels than the R isoform in progenitor cells, but its
expression dramatically decreases while the expression of the
R isoform remains roughly constant throughout the differentia-
tion process. Similar to most other proteins involved in the
Embden-Meyerhof or the pentose phosphate pathways, G6PD
roughly followed the same decrease as the overall cell protein
content (Figure 6). In contrast, the levels of several proteins
involved in redox regulation decreased less than the overall pro-
tein content during the differentiation process. This was espe-
cially true for CYB5R3, which uses NADH to reduce iron in
methemoglobin, as well as for thioredoxin and catalase. Subse-
quently, these proteins were enriched and likely to increase the
redox capacity of erythrocytes. Overall, our data show that
only GLUT1 expression is hugely increased during erythroid dif-
ferentiation at the protein level, suggesting that increasing
glucose and DHA uptake capacities while fine-tuning some
steps in the redox system appear sufficient to fulfill the specific
needs of erythrocytes.
Protein Segregation during Enucleation
In mammals, erythroid cells expel their nucleus at the end of dif-
ferentiation, giving rise to a pyrenocyte and a reticulocyte that ul-
timately matures to an erythrocyte. Due to a lack of an ATP-pro-
ducing system, pyrenocytes are highly unstable and are rapidly
engulfed by macrophages in vivo. They rapidly disintegrate in
cell culture. To simultaneously compare the reticulocytes and
pyrenocytes produced, we sampled the cells at the onset of
the enucleation phase using an appropriate cell culture protocol
(Giarratana et al., 2011). At this time, the cell culture contained
erythroblasts, pyrenocytes, and reticulocytes (Figure 7A). The
cells were separated by fluorescence-activated cell sorting
(FACS) according to size, DNA content, and surface expression
of GPA (Figure 7B).
To verify the quality of the cell preparation, equal numbers of
sorted pyrenocytes and reticulocytes were mixed and analyzed
by absolute LFQ (Table S2). From these data, we calculated that
the sum of the protein amounts for one reticulocyte and one pyr-
enocyte was 44.1 pg, a value very similar to the protein content
of an Ortho cell (39 ± 9 pg; see Figure 3E). Moreover, Pearson
correlation analysis showed a high similarity between the prote-
ome of Ortho cells and of the 1:1 mixture of pyrenocytes and re-
ticulocytes, with a correlation coefficient of 0.93. Because the
protein composition of pyrenocytes and reticulocytes is very
different, a label-free analysis strategy could not be used to
quantify proteins associated with each cell, and their proteomes
were compared after ITRAQ labeling. Cells from three indepen-
dent cell cultures were analyzed to determine the relative distri-
bution of 1,318 proteins (Figure 7C; Table S5). Althoughmost nu-
clear proteins segregated with the pyrenocyte as expected,
cytosolic and membrane proteins distributed differentially de-
pending on the protein, with some of them completely segre-
gating with either the pyrenocyte or the reticulocyte.
To determine whether a protein segregates evenly between
the two cell types or whether it is actively sorted, we determined
the distribution of the compartment where it was embedded.
Although the reticulocyte volume and cell surface area have
been determined previously (Da Costa et al., 2001; Kim et al.,1480 Cell Reports 16, 1470–1484, August 2, 20162014b), these values are lacking for pyrenocytes. To determine
them, we used an imaging flow cytometry approach. The cell
surfaces of both cell types were labeled with anti-GPA anti-
bodies, whereas nuclei were labeled with Hoechst 33342. Eryth-
roblasts were identified according to their size and filtered out.
Pyrenocytes, nuclei, and reticulocytes were considered spher-
ical objects, leading to the determination of cytoplasmic volumes
of 219 ± 54 fl and 49 ± 11 fl and plasmamembrane surface areas
of 175 ± 29 mm2 and 110 ± 12 mm2 for reticulocytes and pyreno-
cytes, respectively (Figure 7D). Although these values have been
obtained using very different methods, they agree well with the
surface and volume of reticulocytes recently determined using
common-path diffraction optical tomography (Kim et al.,
2014b). Thus, around 82% of the cytoplasm and 61% of the
plasma membrane segregated with the reticulocyte during
enucleation.
Several proteins showed unexpected localizations. Although
all histones entirely segregated with the nucleus, the exception
was H4, with 41% found in the reticulocyte. Based on the copy
number of H4 determined in Ortho cells, a very large number
of copies of H4, about 45 3 106 copies, were present in each
reticulocyte. The reason why H4 is partly exported from the nu-
cleus is unclear. It is tempting to suppose that this could favor
nuclear condensation, although a specific role for H4 in the retic-
ulocyte cannot be excluded. Whatever the role of H4 export to
the reticulocyte, mature erythrocytes no longer contain histones
(Lange et al., 2014). Our data show that 67% of the 112,000 20S
proteasome particles segregated with the reticulocyte, indi-
cating that the reticulocyte maintains a high capacity of protein
degradation sufficient to manage the removal of proteins not to
be included in erythrocytes. Overall repartition of 454 proteins
with a nuclear localization according to GO was quantified,
and the median value of their repartition was 84.4% toward the
pyrenocyte (Figure 7E). Thus, although some proteins such as
H4 are specifically exported to the cytoplasm and segregate
with the reticulocyte, our data do not support the previously re-
ported massive export of nuclear proteins at the end of the
erythroid differentiation process in mice (Hattangadi et al., 2014).
Overall, our results show that many cytoplasmic and mem-
brane proteins appear to be specifically sorted to one or the
other cell type, because their distribution does not agree with
the overall distribution of the cell compartment in which they
should be located (Figure 7E; Table S6). Particularly, proteins
of the red cell membrane seem to be actively sorted to the retic-
ulocyte, whereas other membrane proteins, such as TFRC or
SLC2A1, most likely follow a random distribution or are even
specifically sorted to the pyrenocyte, such as ITGB1 or CD36.
Conclusions
Our data provide a detailed description of the entire proteome
of differentiating erythroid cells, demonstrating the capacity of
current proteomic approaches to provide the absolute quantifi-
cation of most cellular proteins during a complex differentiation
process using limited amounts of biological material. Absolute
quantification is a key improvement to the whole proteomic
analyses required to fuel the development of theoretical models
describing and simulating cell behavior. Several approaches to
achieve this goal recently have been initiated. Beck et al.
Figure 7. Protein Sorting during Enucleation
(A) Pyrenocytes and reticulocytes were purified from late erythroid cultures by FACS through DNA (Hoechst 33342) and GPA quantification and cell size.
(B) Flow cytometry analysis of late erythroid culture is shown.
(legend continued on next page)
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(2011) used spiked heavy peptides to quantify selected proteins
and calculated the expression of other proteins from the quanti-
fied protein markers, whereas Wisniewski et al. (2014) used the
invariant histone levels to internally standardize the quantifica-
tion data. Our results confirm the accuracy of this method (see
Figures 3E–3G). As reported by Wisniewski et al. (2014), we
observed that the dynamic range of protein expression encom-
passes seven logs, although it is unclear whether this represents
the current technical limitation of protein quantification in these
global proteomic studies or the true range of protein expression.
We could detect several proteins expressed at levels of a few
hundred copies per cell, such as MYC or MYB, although several
erythroid regulators such as EPOR or JAK2, although detected,
could not be precisely quantified. Scatchard analysis using ra-
diolabeled EPO has shown that erythroid progenitors express
around 500 EPORs per cell (Mayeux et al., 1987). Overall, this
suggests that the coverage of proteins expressed below a few
thousand copies per cell is incomplete in our study. Of the
10,000 genes shown to be expressed in the previous transcrip-
tome analysis, our proteomic study detected around 75% of
the erythroid proteins encoded by these genes, with more than
60% of these proteins quantified. Although further technical im-
provements are still needed to cover the whole erythroid prote-
ome, especially at the quantitative level, our data constitute a
significant improvement in the global description of erythropoi-
esis, and they provide an important toolbox for the understand-
ing of the erythroid differentiation process and its deregulations
in pathologies leading to erythroid deficiencies, such as myelo-
dysplastic syndromes, thalassemia, and Diamond-Blackfan
anemia. The protein expression values are freely available in a
user-friendly web site dedicated to red cell physiology and pa-
thologies (http://www.dsimb.inserm.fr/respire/).
EXPERIMENTAL PROCEDURES
A detailed version of the experimental procedures is available as the Supple-
mental Experimental Procedures.
Erythroid Cell Culture and Characterization
A two-step culture method was adapted from Freyssinier et al. (1999) to obtain
highly stage-enriched erythroblast populations. Briefly, CD34+ progenitors
were purified from human cord blood and cultured for 7 days with IL6, IL3,
and SCF to expand hematopoietic progenitors. Then, CD36+ erythroid progen-
itors were purified and cultured for 3 days with EPO, IL3, SCF, and dexameth-
asone; for 3 days with EPO, human serum, and decreasing concentrations of
SCF, then for 5 days with EPO and fetal calf serum. Each day cells were char-
acterized by flow cytometry for CD34, CD36, GPA, CD71, CD49d, and band 3,
by MGG staining and by benzidine staining for hemoglobinization, and they
were sampled for proteomic analysis. To optimize the enucleation rate, a
slightly modified culture protocol was used for reticulocyte and pyrenocyte
sorting (Giarratana et al., 2011).(C) Results from ITRAQ analysis. The proteins were separated to their main subc
annotations.
(D) Imaging flow cytometry. Images from pyrenocytes and reticulocytes were selec
the pyrenocyte. The radii of these objects were calculated by assuming a spherica
the objects (mean ± SD, n = 1,900 for pyrenocytes and 3,800 for reticulocytes).
(E) The percentage of each protein segregating with the reticulocyte was calculat
using GOCC annotations. Protein lists for each cellular compartment are presente
cytoplasm volume (green area) or the plasma membrane area (pink area) segrega
value for the proteins of each compartment. Erythroid complexes refer to the an
1482 Cell Reports 16, 1470–1484, August 2, 2016LFQ Proteomic Analyses
Peptides were prepared from whole-cell lysates, using the filter-aided sample
preparation (FASP) method essentially as previously described (Wisniewski
et al., 2009), and fractionated by strong cationic exchange (SCX) StageTips
(Kulak et al., 2014). MS analyses were performed on a Dionex U3000 RSLC
nano-LC-system coupled to either a Q-Exactive or an Orbitrap-Velos mass
spectrometer (Thermo Fisher Scientific). Peptides were separated on a C18
reverse-phase resin (75-mm inner diameter and 15-cm length) with a 3-hr
gradient. The mass spectrometer acquired data throughout the elution pro-
cess and operated in a data-dependent scheme.
LFQ Data and Statistical Analyses
The MS data were processed by MaxQuant version 1.5.2.8 (Cox et al., 2014)
using human sequences from the Uniprot-Swiss-prot database (Uniprot,
release 2015-02) with a false discovery rate below 1% for both peptides and
proteins. Label-free protein quantification was done using unique and razor
peptides.
For bioinformatic analysis, LFQ results from MaxQuant were imported into
Perseus software (version 1.5.1.6). Protein copy numbers per cell were then
calculated using the Protein ruler plugin of Perseus by standardization to the
total histone MS signal, as recently described (Wisniewski et al., 2014).
Each experiment corresponding to a whole culture from a single cord blood
sample was analyzed separately in MaxQuant. Mean ± SD and coefficient of
variation values were calculated on the basis of the absolute quantification
values determined using Perseus, as described above. The type of statistical
analysis performed is indicated with each result; ANOVA, Spearman’s rank
correlation, Pearson correlation, and hierarchical clustering analyses were
done using Perseus. Over-/underrepresentation analyses (ORA) were done
using GeneTrail with false discovery rate adjustment according to Benjamini
and Hochberg with p < 0.01 and an observed/predicted ratio > 2.
ITRAQ Quantification
Proteins from whole-cell lysates were digested using the FASP method and
labeled with ITRAQ reagents according to the manufacturer’s instructions.
After mixing, the peptides were separated by isoelectric focalization using
an Agilent 3100 Off-Gel fractionator and analyzed by LC-MS/MS using an
Orbitrap Velos mass spectrometer. The mass spectrometer acquired data
throughout the 2-hr elution process with full MS scans acquired with the Orbi-
trap, followed by up to ten linear trap quadrupole (LTQ) MS/MS collision-
induced dissociation (CID) spectra and ten MS/MS higher-energy collisional
dissociation (HCD) spectra of the most abundant ions detected in the MS
scan. The data were first analyzed using Proteome Discoverer 1.3 to produce
mgf files after merging the HCD and CID scans. The files were then analyzed
using Protein Pilot v4 using the Uniprot human database.
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per are from ProteomeXchange Consortium (http://www.proteomexchange.
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Supplemental Information includes Supplemental Experimental Procedures,
four figures, and six tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.06.085.ellular compartment according to Gene Ontology cellular component (GOCC)
ted andmasks were drawn to delineate the limits of the cells and the nucleus in
l shape for all of these objects and used to determine the volume and surface of
ed and the proteins were classified according to their subcellular compartment
d in Table S6. The shaded area represents the 95% confidence interval for the
ting with the reticulocyte, and the horizontal bars show the median repartition
kyrin and band 4.1 complexes of the erythrocyte.
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